We also observed no differences in mRNA levels of PSA (Fig 4B), the proliferation markers PCNA (Fig. 5A) or Ki-67 (Fig. 5B) between control (n=4) and PEITC-treated (n=4) tumor samples. Here, KLK3 is linked to neoplasm.